Clinical Trial

BMI-Associated Labor Induction: A Prospective Trial

Study Description

BMI-Associated Labor Induction: A Prospective Trial

The primary objective of this study is to determine if planned induction of labor at 39 weeks for nulliparous with pre-pregnancy BMI a?Y 35 kg/m2 reduces the incidence of cesarean section compared to expectant management

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Procedure - Labor induction

The study intervention is labor induction from 39 0/7 to 39 6/7 weeks. The individual labor induction process will be at the discretion of the physician or midwife managing the subject's care. Methods of induction that may be used include misoprostol, intracervical Foley catheter, oxytocin, and/or amniotomy. Participating clinicians will be encouraged to use only one course of cervical ripening followed by oxytocin infusion and amniotomy.

Additional Information

Official Study Title

BMI-Associated Labor Induction: A Prospective Trial

Clinical Trial ID

NCT04035382

ParticipAid ID

dwpz1e